pharma · STEMI
Beijing Luzhu Biopharmaceutical
Beijing Luhe Hospital
Beijing Luhe Hospital is a pharma organization headquartered in CN. Primary therapeutic focus areas include STEMI. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from
Beijing, CN HQ
2 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- Beijing, CN
- Employees
- 2
- Programs
- 1
- Drugs
- 1
- Patents
- 0
evolocumab
Unknown · small molecule · STEMI
evolocumab for STEMI is a Unknown program (small_molecule) at Beijing Luhe Hospital with 1 ClinicalTrials.gov record(s).
Internal code MR-11-23-035852
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Beijing Luhe Hospital
- Phase
- Unknown
- Modality
- small_molecule
- Indication
- STEMI
- Status
- active
- Trials
- 1